Regulation of human NK-cell cytokine and chemokine production by target cell recognition.

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Blood

• Publication date

  2010-03-18

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1182/blood-2009-08-238469PMID 19965656PMCID PMC2844017
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Interleukin-22-producing natural killer cells and lymphoid tissue inducer-like cells in mucosal immunity.

  2009cited by this paper
• Minimal requirement for induction of natural cytotoxicity and intersection of activation signals by inhibitory receptors.

  2009cited by this paper
• The B7 family member B7-H6 is a tumor cell ligand for the activating natural killer cell receptor NKp30 in humans

  2009cited by this paper
• Line of attack: NK cell specificity and integration of signals.

  2008cited by this paper
• Functionally distinct NK‐cell subsets: Developmental origins and biological implications

  2008cited by this paper
• Natural killer cells: diversity in search of a niche

  2008cited by this paper
• Functions of natural killer cells

  2008cited by this paper
• Application of CD27 as a marker for distinguishing human NK cell subsets.

  2008cited by this paper
• Human natural killer cells.

  2008cited by this paper
• Stat4-dependent, T-bet-independent regulation of IL-10 in NK cells

  2008cited by this paper
• HLA alleles determine differences in human natural killer cell responsiveness and potency

  2008cited by this paper
• Natural killer cells in immunodefense against infective agents

  2008cited by this paper
• Application of nine-color flow cytometry for detailed studies of the phenotypic complexity and functional heterogeneity of human lymphocyte subsets.

  2008cited by this paper
• Non‐cytotoxic protection by human NK cells in mucosal secondary lymphoid tissues

  2008cited by this paper
• The PP2A inhibitor SET regulates natural killer cell IFN-γ production

  2007cited by this paper
• Keeping NK cells in highly regulated antiviral warfare.

  2007cited by this paper
• DNAX accessory molecule-1 mediated recognition of freshly isolated ovarian carcinoma by resting natural killer cells.

  2007cited by this paper
• CD56brightCD16− Killer Ig-Like Receptor− NK Cells Display Longer Telomeres and Acquire Features of CD56dim NK Cells upon Activation1

  2007cited by this paper
• Natural killer cells produce T cell-recruiting chemokines in response to antibody-coated tumor cells.

  2006cited by this paper
• Interleukin-21 Enhances NK Cell Activation in Response to Antibody-Coated Targets1

  2006cited by this paper
• Human natural killer cell development

  2006cited by this paper
• Human NK cell education by inhibitory receptors for MHC class I.

  2006cited by this paper
• Activation, coactivation, and costimulation of resting human natural killer cells

  2006cited by this paper
• Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion.

  2006cited by this paper
• Natural killer cells as an initial defense against pathogens

  2006cited by this paper
• NK cell recognition.

  2005cited by this paper
• Differential expression of SHIP1 in CD56bright and CD56dim NK cells provides a molecular basis for distinct functional responses to monokine costimulation.

  2005cited by this paper
• Cytolytic granule polarization and degranulation controlled by different receptors in resting NK cells

  2005cited by this paper
• Cellular ligands of activating NK receptors.

  2005cited by this paper
• NK Cell Compartments and Their Activation by Dendritic Cells1

  2004cited by this paper
• Signaling by IL‐12 and IL‐23 and the immunoregulatory roles of STAT4

  2004cited by this paper
• Leukocyte functional antigen 1 lowers T cell activation thresholds and signaling through cytohesin-1 and Jun-activating binding protein 1

  2003cited by this paper
• Cutting Edge: Immune Cells as Sources and Targets of the IL-10 Family Members?

  2002cited by this paper
• UL16-Binding Proteins, Novel MHC Class I-Related Proteins, Bind to NKG2D and Activate Multiple Signaling Pathways in Primary NK Cells

  2002cited by this paper
• Human natural killer cells : a unique innate immunoregulatory role for the CD 56 bright subset

  2001cited by this paper
• The biology of human natural killer-cell subsets.

  2001cited by this paper
• CD56bright cells differ in their KIR repertoire and cytotoxic features from CD56dim NK cells

  2001cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56bright subset

  2001cited by this paper
• Human natural killer cells: a unique innate immunoregulatory role for the CD56(bright) subset.

  2001cited by this paper
• Differential cytokine and chemokine gene expression by human NK cells following activation with IL-18 or IL-15 in combination with IL-12: implications for the innate immune response.

  1999cited by this paper
• Natural killer cells in antiviral defense: function and regulation by innate cytokines.

  1999cited by this paper
• Identification and Molecular Characterization of Nkp30, a Novel Triggering Receptor Involved in Natural Cytotoxicity Mediated by Human Natural Killer Cells

  1999cited by this paper
• Natural killer cells from human immunodeficiency virus (HIV)-infected individuals are an important source of CC-chemokines and suppress HIV-1 entry and replication in vitro.

  1998cited by this paper
• Differentiation of human NK cells into NK1 and NK2 subsets.

  1998cited by this paper
• Human natural killer cells produce abundant macrophage inflammatory protein-1 alpha in response to monocyte-derived cytokines.

  1996cited by this paper
• Production of IL-5 by human NK cells and regulation of IL-5 secretion by IL-4, IL-10, and IL-12.

  1995cited by this paper
• Requirement for natural killer cell-produced interferon gamma in defense against murine cytomegalovirus infection and enhancement of this defense pathway by interleukin 12 administration

  1995cited by this paper
• Interleukin (IL) 15 is a novel cytokine that activates human natural killer cells via components of the IL-2 receptor

  1994cited by this paper
• Natural killer cells are a source of interferon gamma that drives differentiation of CD4+ T cell subsets and induces early resistance to Leishmania major in mice

  1993cited by this paper
• Interleukin 12 is required for the T-lymphocyte-independent induction of interferon gamma by an intracellular parasite and induces resistance in T-cell-deficient hosts.

  1993cited by this paper
• Regulation of gamma interferon production by natural killer cells in scid mice: roles of tumor necrosis factor and bacterial stimuli

  1991cited by this paper
• IL-8 gene expression and production in human peripheral blood lymphocyte subsets.

  1991cited by this paper
• Production of hematopoietic colony-stimulating factors by human natural killer cells

  1989cited by this paper
• A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of Fc gamma RIII.

  1989cited by this paper
• Co-association of CD3ζ with a receptor (CD16) for IgG Fc on human natural killer cells

  1989cited by this paper
• A single amino acid in the glycosyl phosphatidylinositol attachment domain determines the membrane topology of FcγRIII

  1989cited by this paper
• Interaction of Fc receptor (CD16) ligands induces transcription of interleukin 2 receptor (CD25) and lymphokine genes and expression of their products in human natural killer cells

  1988cited by this paper
• Natural killer cells: definition of a cell type rather than a function.

  1986cited by this paper
• The relationship of CD16 (Leu-11) and Leu-19 (NKH-1) antigen expression on human peripheral blood NK cells and cytotoxic T lymphocytes.

  1986cited by this paper
• Human natural killer cells.

  1979cited by this paper

• Integrative Roles of NK Receptors and γδ TCRs in γδ T Cell-Mediated Cancer Immunity.

  2026cites this paper
• Key immune cells in the tumor immune microenvironment of colorectal cancer: Roles and research advances (Review)

  2026cites this paper
• Gene Regulatory Programs of NK Cells Show That NCAM1 (CD56) and KIRs Are Controlled by Genetically Polymorphic Distal Regulatory Elements

  2026cites this paper
• Resident CD49a+CD103+NKG2C+ NK cells restrict HIV infection in human lymphoid tissue explants

  2026cites this paper
• Bromodomain and extra-terminal proteins in solid tumors: regulators of immune microenvironment and emerging therapeutic targets

  2026cites this paper
• Immune dysregulation in COVID-19: Mathematical modeling of the within-host dynamics

  2026cites this paper
• Discovery and preclinical evaluation of monoclonal antibodies and bispecific engagers targeting the NKG2A inhibitory receptor

  2026cites this paper
• Optimal genetic feeder cell-expanded and engineered NK cell products are composed of CD56bright and CD56dim NK cells

  2026cites this paper
• Cell-free secretome of CD56brightCD16bright directly reprogrammed NK cells enhances wound healing via CCL3/4/5-CCR5 signaling

  2026cites this paper
• Functions and clinical implications of the liver microenvironment in hepatic uveal melanoma metastases

  2025cites this paper
• Understanding the Mode of Action of Several Active Ingredients from the Micro-Immunotherapy Medicine 2LZONA®

  2025cites this paper
• Machine Learning-Driven Identification of Blood-Based Biomarkers and Therapeutic Agents for Personalized Ischemic Stroke Management

  2025cites this paper
• EGFR: New Insights on Its Activation and Mutation in Tumor and Tumor Immunotherapy

  2025cites this paper
• Modelling Immune Dynamics in Locally Advanced MSI-H/dMMR Colorectal Cancer with Neoadjuvant Pembrolizumab Treatment: From Differential Equations to an Agent-Based Framework

  2025cites this paper
• Derivation of functional early gestation decidual natural killer cell subtypes from induced pluripotent stem cells

  2025cites this paper
• Nanoscale restructuring of the immune synapse with an engager enhances NK cell function

  2025cites this paper
• The clinical landscape of CAR NK cells

  2025cites this paper
• Exhausted natural killer cells in adult IgA vasculitis

  2025cites this paper
• Naturally arising memory-phenotype CD4+ T lymphocytes give rise to multiple helper subsets to contribute to tumor immunity while inhibiting GVHD.

  2025cites this paper
• Aging and immunity: the age-old tango

  2025cites this paper
• Immune profiling of kidney transplant recipients: the role of Tribbles-1, Perforin, and Granzyme B in chronic humoral rejection

  2025cites this paper
• Harnessing the potential of CAR-NK cell therapy in gastrointestinal cancers: From bench to bedside.

  2025cites this paper
• Immunotherapy of chimeric antigen receptor NK cells: status and its promising future

  2025cites this paper
• Unveiling Activated NK Cell Dynamics in Salmonella Typhi Infection Under Optimum Double‐Drug (Azithromycin and IFN−γ) Therapy: An Immuno‐Mathematical Model Analysis

  2025cites this paper
• Leveraging the heterogeneity of the NK cell repertoire for the development of immunotherapies for acute leukemia

  2025cites this paper
• Unveiling the Interplay Between Dendritic Cells and Natural Killer Cells as Key Players in Leishmania Infection

  2025cites this paper
• NKG2A-mediated immune modulation of natural killer cells by Staphylococcus aureus

  2025cites this paper
• Synergistic Anti-Tumor Efficacy of Modified FOLFIRINOX and NK Cell Therapy in Pancreatic Ductal Adenocarcinoma

  2025cites this paper
• CD73 promotes the maturation of murine NK cells and their survival in the tumor microenvironment.

  2025cites this paper
• Immune cells: the key mediator between the gut microbiota and osteoporosis

  2025cites this paper
• Inflammasome Profiling in Human Natural Killer Cells under Pro-inflammatory Stimuli and Solid Organ Transplantation

  2025cites this paper
• A New Antibody–Cytokine Construct Targeting Natural Killer Cells: An Immunotherapeutic Approach to Chronic Lymphocytic Leukemia

  2025cites this paper
• Anti-inflammatory phenotypes of immune cells after myocardial infarction and prospects of therapeutic strategy

  2025cites this paper
• The immune response to human cytomegalovirus: impact of age, co-morbidities and the significance of anti-viral activity assessment

  2025cites this paper
• CD155 density on target cells drives divergent natural killer cell responses owing to DNAM-1 loss

  2025cites this paper
• The cross talk between protein misfolding and tumor microenvironment dynamics.

  2025cites this paper
• Epigenetic attenuation of interferon signaling is associated with aging-related improvements in systemic lupus erythematosus.

  2025cites this paper
• Chimeric antigen receptor cell therapy: A revolutionary approach transforming cancer treatment to autoimmune disease therapy.

  2025cites this paper
• Optimising Chemotherapy for Advanced High-Grade Serous Ovarian Cancer via Delay-Differential Equations

  2025cites this paper
• Engineering innate immune cells for cancer immunotherapy

  2025cites this paper
• Immune signatures and biomarkers of viral control in early-treated children with HIV: insights informing intervention

  2025cites this paper
• Anti-SARS-CoV-2 and Immunomodulatory Activity of Marine Bacteria Polysaccharides

  2025cites this paper
• Adoptive transfer of natural killer cells in therapeutic treatment of COVID-19 patients

  2025cites this paper
• Meningococcal vaccine 4CMenB elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection

  2025cites this paper
• Immunotherapy for hypertensive end-organ damage: a new therapeutic strategy

  2025cites this paper
• Role of CCL2/CCR2 axis in pulmonary fibrosis induced by respiratory viruses.

  2025cites this paper
• A chimeric antigen receptor tailored to integrate complementary activation signals potentiates the antitumor activity of NK cells

  2025cites this paper
• Modification of soluble dietary fiber from quinoa bran and investigation of its anticancer activity in vitro

  2025cites this paper
• HIV-1 infection of macrophages differentially primes NK-cell cytotoxicity and proinflammatory cytokine production

  2025cites this paper
• Engineering immunity with CAR-NK cells: advancing the frontiers of cancer immunotherapy

  2025cites this paper
• The effects of bone marrow humoral components of B-cell acute lymphoblastic leukemia patients on natural killer cell suppression

  2025cites this paper
• Natural born Killers: Harnessing NK cells to treat cancer.

  2025cites this paper
• Cd16-Cd56bright NK Cells: A Protective NK Cell Subset for Progression and Prognosis in Amyotrophic Lateral Sclerosis

  2025cites this paper
• The causal effect of natural killer cells on COVID-19 infection, hospitalization and severity

  2025cites this paper
• Alloreactive-free CAR-VST therapy: a step forward in long-term tumor control in viral context

  2025cites this paper
• Inhibition of TIGIT on NK cells improves their cytotoxicity and HIV reservoir eradication potential

  2025cites this paper
• Natural killer cell-specific chimeric antigen receptor enhances CAR NK cell functions and anti-tumor activity

  2025influential citation
• Improving cell-type composition inference in spatial transcriptomics with SpaDAMA

  2025cites this paper
• Enhanced Immune Functions of In Vitro Human Natural Killer Cells and Splenocytes in Immunosuppressed Mice Supplemented with Mature Silkworm Products

  2025cites this paper
• Clonal stochasticity in early NK cell response to mouse cytomegalovirus is generated by mature subsets of varying proliferative ability

  2025cites this paper
• Increased Chemokine Production is a Hallmark of Rhesus Macaque Natural Killer Cells Mediating Robust Anti-HIV Envelope-Specific Antibody-Dependent Cell-Mediated Cytotoxicity

  2025cites this paper
• Targeting Cancer: Microenvironment and Immunotherapy Innovations

  2024cites this paper
• Circular RNA circPHLPP2 promotes tumor growth and anti-PD-1 resistance through binding ILF3 to regulate IL36γ transcription in colorectal cancer

  2024cites this paper
• Soluble factors released by peripheral blood-derived CAR-NK cells cause bystander myeloid cell activation

  2024cites this paper
• Optimisation of neoadjuvant pembrolizumab therapy for locally advanced MSI-H/dMMR colorectal cancer using data-driven delay integro-differential equations.

  2024cites this paper
• CAR beyond the classical CAR-T: functional features and application prospects (review)

  2024cites this paper
• Natural killer cell-based therapies in neuroblastoma.

  2024cites this paper
• Impact of Psychological Stressors on Natural Killer Cell Function: A Comprehensive Analysis based on Stressor Type, Duration, Intensity, and Species.

  2024cites this paper
• The Influence of Dietary Patterns on Immune Function and Inflammation

  2024cites this paper
• Cytokine‐armed vaccinia virus promotes cytotoxicity toward pancreatic carcinoma cells via activation of human intermediary CD56dimCD16dim natural killer cells

  2024cites this paper
• NK Cells: Not Just Followers But Also Initiators of Chronic Vascular Rejection

  2024cites this paper
• CX3CL1 (Fractalkine): An important cytokine in physiological and pathological pregnancies.

  2024cites this paper
• Nature killer cell for solid tumors: Current obstacles and prospective remedies in NK cell therapy and beyond.

  2024cites this paper
• Prospective Molecular Targets for Natural Killer Cell Immunotherapy against Glioblastoma Multiforme

  2024cites this paper
• Euglena gracilis Enhances Innate and Adaptive Immunity through Specific Expression of Dectin-1 in CP-Induced Immunosuppressed Mice

  2024cites this paper
• Natural killer cells in neuroblastoma: immunological insights and therapeutic perspectives

  2024cites this paper
• Feeder cell training shapes the phenotype and function of in vitro expanded natural killer cells

  2024cites this paper
• Meningococcal vaccine Bexsero elicits a robust cellular immune response that targets but is not consistently protective against Neisseria gonorrhoeae during murine vaginal infection

  2024cites this paper
• The YTH domain‐containing protein family: Emerging players in immunomodulation and tumour immunotherapy targets

  2024cites this paper
• CD38-CAR human NK cells in combination with ATRA enhance cytotoxicity against CD38-expressing hematologic malignancies

  2024cites this paper
• Expression of a stress-inducible heme oxygenase-1 in NK cells is maintained in the process of human aging

  2024cites this paper
• Development in the Study of Natural Killer Cells for Malignant Peritoneal Mesothelioma Treatment

  2024cites this paper
• Simulated microgravity impairs human NK cell cytotoxic activity against space radiation-relevant leukemic cells

  2024cites this paper
• Distinct developmental pathways generate functionally distinct populations of natural killer cells

  2024cites this paper
• Beyond CAR-T: The rise of CAR-NK cell therapy in asthma immunotherapy

  2024cites this paper
• Immunology of Cytokine Storm Syndromes: Natural Killer Cells.

  2024cites this paper
• Immunological features of EGFR-mutant non-small cell lung cancer and clinical practice: a narrative review

  2024cites this paper
• Aging brought additional immune response alterations after breakthrough infections with the Omicron BA.5/BF.7 variants: Protein immune mechanism.

  2024cites this paper
• The Spectrum of CAR Cellular Effectors: Modes of Action in Anti-Tumor Immunity

  2024influential citation
• First-line penpulimab (an anti-PD1 antibody) and anlotinib (an angiogenesis inhibitor) with nab-paclitaxel/gemcitabine (PAAG) in metastatic pancreatic cancer: a prospective, multicentre, biomolecular exploratory, phase II trial

  2024cites this paper
• Non-viral approaches in CAR-NK cell engineering: connecting natural killer cell biology and gene delivery

  2024cites this paper
• Correlation of High-Grade Osteosarcoma Response to Chemotherapy with Enhanced Tissue Immunological Response: Analysis of CD95R, IFN-γ, Catalase, Hsp70, and VEGF

  2024cites this paper
• Simulated Microgravity Impairs Human NK Cell Cytotoxic Activity Against Space Radiation-Relevant Leukemic Cells

  2024cites this paper
• Tumor-associated NK cells drive MDSC-mediated tumor immune tolerance through the IL-6/STAT3 axis

  2024cites this paper
• Evolution of natural killer cell-targeted therapy for acute myeloid leukemia

  2024cites this paper
• Advanced Immunomodulatory Biomaterials for Therapeutic Applications

  2024cites this paper
• NK-cell receptor modulation in viral infections

  2024cites this paper
• Efbalropendekin Alfa enhances human natural killer cell cytotoxicity against tumor cell lines in vitro

  2024cites this paper
• Elotuzumab Enhances CD16-Independent NK Cell-Mediated Cytotoxicity against Myeloma Cells by Upregulating Several NK Cell-Enhancing Genes

  2024cites this paper
• Extrinsic and intrinsic drivers of natural killer cell clonality

  2024cites this paper